Breast Lesion Localization Companies

Top Industry Leaders in the Breast Lesion Localization Market

Breast Lesion Localization Key Companies

Latest Breast Lesion Localization Companies Update:

Merit Medical Systems (US) launches Scout Bx, a wireless, radar-guided localization system for accurate identification of biopsied tumors during lumpectomy surgery.

Leica Biosystems Nussloch GmbH (Germany) introduces the DualCore Dual Stage Core Biopsy System, the first dual-stage instrument for needle biopsies, offering improved sample acquisition and tissue preservation.

Cianna Medical (US) receives FDA approval for its EchoMark™ Smart Marker System, a wire-free, ultrasound-guided localization device for breast lesions.

Cook Medical (US) expands its portfolio with the InEcho™ Intraoperative Localization System, a wire-free, electromagnetic method for guiding surgeons to non-palpable breast lesions.

Eckert & Ziegler AG (Germany) acquires IsoAid Ltd. (UK), gaining access to IsoAid's SENTINEL™ radioisotope markers for breast lesion localization.

List of Breast Lesion Localization Key companies in the market

D. Company (US)

Cianna Medical (US)

Cook Medical (US)

Endomagnetics Ltd (UK)

Health Beacon (Ireland)

Intra medical imaging

Devicor Medical Products Inc (US)

Somatex Medical Technologies GmbH (Germany)

Surgiceye GmbH (Germany)

Ranfac Corporation (US)

Breast lesion localization is a procedure used in breast surgery to accurately identify and guide the removal of abnormal lesions or tumors. This is often done using localization devices or techniques to precisely mark the location of the lesion for surgical excision.

Top Industry Leaders in the Breast Lesion Localization Market